Search Results - "LaRocca, Nicholas G"

Refine Results
  1. 1

    Symbol Digit Modalities Test: A valid clinical trial endpoint for measuring cognition in multiple sclerosis by Strober, Lauren, DeLuca, John, Benedict, Ralph HB, Jacobs, Adam, Cohen, Jeffrey A, Chiaravalloti, Nancy, Hudson, Lynn D, Rudick, Richard A, LaRocca, Nicholas G

    Published in Multiple sclerosis (01-11-2019)
    “…Background: The need for more robust outcomes in multiple sclerosis (MS) clinical trials has been a main priority of the field for decades. Dissatisfaction…”
    Get full text
    Journal Article
  2. 2

    Impact of Walking Impairment in Multiple Sclerosis: Perspectives of Patients and Care Partners by LaRocca, Nicholas G.

    “…Background: Multiple sclerosis (MS) is a chronic neurologic disease associated with gait impairment that adversely affects quality of life (QOL). Data are…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5
  6. 6

    Validation of an algorithm for identifying MS cases in administrative health claims datasets by Culpepper, William J, Marrie, Ruth Ann, Langer-Gould, Annette, Wallin, Mitchell T, Campbell, Jonathan D, Nelson, Lorene M, Kaye, Wendy E, Wagner, Laurie, Tremlett, Helen, Chen, Lie H, Leung, Stella, Evans, Charity, Yao, Shenzhen, LaRocca, Nicholas G

    Published in Neurology (05-03-2019)
    “…OBJECTIVETo develop a valid algorithm for identifying multiple sclerosis (MS) cases in administrative health claims (AHC) datasets. METHODSWe used 4 AHC…”
    Get full text
    Journal Article
  7. 7

    Computerized neuropsychological assessment devices in multiple sclerosis: A systematic review by Wojcik, Curtis M, Beier, Meghan, Costello, Kathleen, DeLuca, John, Feinstein, Anthony, Goverover, Yael, Gudesblatt, Mark, Jaworski, Michael, Kalb, Rosalind, Kostich, Lori, LaRocca, Nicholas G, Rodgers, Jonathan D, Benedict, Ralph HB

    Published in Multiple Sclerosis Journal (01-12-2019)
    “…Background: The proliferation of computerized neuropsychological assessment devices (CNADs) for screening and monitoring cognitive impairment is increasing…”
    Get full text
    Book Review Journal Article
  8. 8

    A new way to estimate neurologic disease prevalence in the United States: Illustrated with MS by Nelson, Lorene M, Wallin, Mitchell T, Marrie, Ruth Ann, Culpepper, W.J, Langer-Gould, Annette, Campbell, Jon, Buka, Stephen, Tremlett, Helen, Cutter, Gary, Kaye, Wendy, Wagner, Laurie, Larocca, Nicholas G

    Published in Neurology (05-03-2019)
    “…OBJECTIVEConsiderable gaps exist in knowledge regarding the prevalence of neurologic diseases, such as multiple sclerosis (MS), in the United States…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    Projecting the Adequacy of the Multiple Sclerosis Neurologist Workforce by Halpern, Michael T, Kane, Heather, Teixeira-Poit, Stephanie, Ford, Corey, Giesser, Barbara, Halper, June, Johnson, Shana, LaRocca, Nicholas G, Miller, Aaron, Ringel, Steven P

    Published in International journal of MS care (01-01-2018)
    “…Anecdotal reports suggest shortages among neurologists who provide multiple sclerosis (MS) patient care. However, little information is available regarding the…”
    Get full text
    Journal Article
  12. 12
  13. 13

    The Multiple Sclerosis Intimacy and Sexuality Questionnaire-19 (MSISQ-19) by Audrey Sorgen Sanders, Foley, Frederick W, LaRocca, Nicholas G, Zemon, Vance

    Published in Sexuality and disability (01-03-2000)
    “…The purpose of the present study was to develop a reliable and valid self-report questionnaire to assess the perceived influence of Multiple Sclerosis (MS)…”
    Get full text
    Journal Article
  14. 14

    Helplessness, self-efficacy, cognitive distortions, and depression in multiple sclerosis and spinal cord injury by Shnek, Z M, Foley, F W, LaRocca, N G, Gordon, W A, DeLuca, J, Schwartzman, H G, Halper, J, Lennox, S, Irvine, J

    Published in Annals of behavioral medicine (1997)
    “…The aim of this study was to determine if learned helplessness, self-efficacy, and cognitive distortions would predict depression in a sample of 80 individuals…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Efficacy of Stress-Inoculation Training in Coping With Multiple Sclerosis by Foley, Frederick W, Bedell, Jeffrey R, LaRocca, Nicholas G, Scheinberg, Labe C, Reznikoff, Marvin

    “…Forty multiple sclerosis (MS) patients were randomly assigned to one of two treatment conditions: stress inoculation training (SIT) or current available care…”
    Get full text
    Journal Article
  17. 17

    The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus by Krupp, L B, LaRocca, N G, Muir-Nash, J, Steinberg, A D

    Published in Archives of neurology (Chicago) (01-10-1989)
    “…Fatigue is a prominent disabling symptom in a variety of medical and neurologic disorders. To facilitate research in this area, we developed a fatigue severity…”
    Get more information
    Journal Article
  18. 18

    Fatigue in multiple sclerosis by Krupp, L B, Alvarez, L A, LaRocca, N G, Scheinberg, L C

    Published in Archives of neurology (Chicago) (01-04-1988)
    “…Fatigue is a frequent symptom in multiple sclerosis (MS) that can interfere with a patient's daily functioning. The cause of MS fatigue, its clinical…”
    Get more information
    Journal Article
  19. 19

    Guidelines for neuropsychological research in multiple sclerosis by Peyser, J M, Rao, S M, LaRocca, N G, Kaplan, E

    Published in Archives of neurology (Chicago) (01-01-1990)
    “…Acquisition of scientific information regarding the neuropsychological aspects of multiple sclerosis has been hampered by studies using small, inadequately…”
    Get more information
    Journal Article
  20. 20

    A prospective study of depression and immune dysregulation in multiple sclerosis by Foley, F W, Traugott, U, LaRocca, N G, Smith, C R, Perlman, K R, Caruso, L S, Scheinberg, L C

    Published in Archives of neurology (Chicago) (01-03-1992)
    “…This study examined psychologic distress and immune function in patients with chronic-progressive multiple sclerosis participating in a placebo-control trial…”
    Get more information
    Journal Article